FDA Adverse Event Malfunction Summary report: N

50 ML BD PLASTIPAK¿ LUER-LOK¿ SYRINGE

MDR report key: 13254544 · Received January 13, 2022

Report

Report Number
3003152976-2021-00901
Event Type
Malfunction
Date Received
January 13, 2022
Date of Event
December 20, 2021
Report Date
March 2, 2022
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 2008337 , MEDICAL DEVICE EXPIRATION DATE: 2025-07-31 , DEVICE MANUFACTURE DATE: 2020-08-07. MEDICAL DEVICE LOT #: 2103502, MEDICAL DEVICE EXPIRATION DATE: 2026-02-28 , DEVICE MANUFACTURE DATE: 2021-03-23 . A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL? YES. D10: RETURNED TO MANUFACTURER ON: 2022-01-24. H6: INVESTIGATION SUMMARY FIFTEEN UNUSED SAMPLES SEPARATED IN THREE BAGS WITH FIVE SYRINGES EACH RECEIVED FOR INVESTIGATION. ONE BAG WITH FIVE SYRINGES BELONG TO LOT 2109085, ANOTHER BAG FROM LOT 2103502, THE THIRD BAG HAVE FIVE SYRINGES WITH TWO LOT NUMBERS: 2008337 OR 2103502. LOT 2109085 WAS SENT BY CUSTOMER FOR COMPARISON PURPOSES. UPON VISUAL INSPECTION OF THE SAMPLES, NO DEFECTS OR ISSUES OBSERVED. STOPPER IS CORRECTLY ASSEMBLED. FUNCTIONAL TESTING IS PERFORMED, NO LEAKAGE OBSERVED. A DEVICE HISTORY REVIEW WAS PERFORMED FOR REPORTED LOTS 2008337,2103502 NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THIS REPORTED ISSUE. FINAL PRODUCTS IN THIS MANUFACTURING LINE, FOR THIS REFERENCE ARE SAMPLED AND THEY ARE SUBJECTED TO VISUAL AND FUNCTIONAL INSPECTIONS DURING THE DIFFERENT MANUFACTURING SUB-PROCESSES ACCORDING TO PROCEDURES, INCLUDING LEAKAGE TESTING TO VERIFY THE STOPPER SEAL. BASED ON THE QUALITY TEAM'S INVESTIGATION, WE ARE NOT ABLE TO IDENTIFY A ROOT CAUSE RELATED TO OUR MANUFACTURING PROCESS AT THIS TIME.

Description of Event or Problem · 0

IT WAS REPORTED THAT 2 50 ML BD PLASTIPAK¿ LUER-LOK¿ SYRINGES EXPERIENCED LEAKAGE PAST THE STOPPER. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WHILE DRAWING UP CYTOSTATICS, MY COLLEAGUE FELT THAT SHE WAS DRAWING SOME AIR, THEN LIQUID ALONG THE PLUNGER ENTERED THE SYRINGE. AND LIQUID RAN ONTO HER GLOVE.

Description of Event or Problem · 0

IT WAS REPORTED THAT 2 50 ML BD PLASTIPAK¿ LUER-LOK¿ SYRINGES EXPERIENCED LEAKAGE PAST THE STOPPER. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WHILE DRAWING UP CYTOSTATICS, MY COLLEAGUE FELT THAT SHE WAS DRAWING SOME AIR, THEN LIQUID ALONG THE PLUNGER ENTERED THE SYRINGE. AND LIQUID RAN ONTO HER GLOVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1018134 50 ML BD PLASTIPAK¿ LUER-LOK¿ SYRINGE SYRINGE FMF BECTON DICKINSON, S.A. SEE H10

Patients

Seq Age Sex Outcome Treatment
1 Unknown